Advisory Alpha’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Sell
2,902
-51
-2% -$25.8K 0.04% 160
2025
Q4
$1.67M Buy
2,953
+655
+29% +$349K 0.05% 137
2025
Q3
$1.02M Buy
2,298
+45
+2% +$21.6K 0.03% 178
2025
Q2
$1.22M Buy
2,253
+147
+7% +$76.9K 0.04% 147
2025
Q1
$1.04M Sell
2,106
-41
-2% -$22.7K 0.04% 157
2024
Q4
$1.12M Buy
2,147
+439
+26% +$229K 0.04% 146
2024
Q3
$839K Buy
1,708
+291
+21% +$135K 0.03% 166
2024
Q2
$630K Buy
1,417
+379
+37% +$151K 0.02% 187
2024
Q1
$414K Buy
+1,038
New +$392K 0.02% 242
2020
Q4
Sell
-60
Closed -$14K 356
2020
Q3
$14K Buy
+60
New +$13.5K ﹤0.01% 376
2020
Q2
Sell
-72
Closed -$12.3K 340
2020
Q1
$12.3K Sell
72
-18
-20% -$3.3K ﹤0.01% 381
2019
Q4
$18.1K Sell
90
-15
-14% -$2.81K ﹤0.01% 419
2019
Q3
$18K Buy
+105
New +$18.2K 0.01% 381
2019
Q2
Sell
-192
Closed -$31.7K 372
2019
Q1
$31.7K Buy
+192
New +$34.1K 0.01% 287

Other funds holding ISRG

Advisory Alpha's ISRG Position: Q1 2026 in Review

Advisory Alpha reduced its Intuitive Surgical (ISRG) stake by 1.7% in Q1 2026, selling an estimated $25.8K and leaving 2,902 shares worth $1.34M. The position accounts for 0.04% of the portfolio, ranked #160.

Advisory Alpha first reported a position in ISRG in Q1 2019 and has held it in 14 quarters since. The position peaked at $1.67M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Advisory Alpha held 2,902 shares of Intuitive Surgical worth $1.34M as of Q1 2026.
  • Advisory Alpha sold 51 Intuitive Surgical shares in Q1 2026, an estimated $25.8K.
  • Intuitive Surgical made up 0.04% of Advisory Alpha's portfolio in Q1 2026, its #160 holding.
  • Advisory Alpha first reported a position in Intuitive Surgical in Q1 2019 and has held it in 14 quarters since.
  • Advisory Alpha's Intuitive Surgical position peaked at $1.67M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.